Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2025-12-17 @ 11:17 AM
Study NCT ID:
NCT06338761
Status:
None
Last Update Posted:
2025-05-21 00:00:00
First Post:
2024-03-24 00:00:00
Brief Title:
Switching to E-cigarette After PCI
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
Prognostic Impact of Switching to E-Cigarette Use in Smokers With Coronary Artery Disease Following Percutaneous Coronary Intervention: A Nationwide Cohort Study
Status:
None
Status Verified Date:
2025-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
E-cig-PCI
Brief Summary:
Recently, several studies have reported that, although lower than combustible cigarette users, E-cigarette users had a significantly higher risk of future myocardial infarction (MI) or cardiovascular disease compared with non-smokers or quitters. However, because all previous studies has focused on the general healthy population, these results cannot be extrapolated for patients who already proven atherosclerotic cardiovascular disease (ASCVD), such as undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Although Busch et al. previously reported that a significant minority of patients are using E-cigarettes post-acute coronary syndrome smokers, a paucity of data exists regarding the impact of such transitions on clinical outcomes in current smoker patients with CAD who have undergone PCI. In light of these considerations, the current study sought to address this gap in knowledge by evaluating the prognostic implications of smoking habit changes, including E-cigarette use, among CAD patients with current smoking status following PCI.
Detailed Description:
Recently several studies have reported that although lower than combustible cigarette users E-cigarette users had a significantly higher risk of future myocardial infarction MI or cardiovascular disease compared with non-smokers or quitters However because all previous studies has focused on the general healthy population these results cannot be extrapolated for patients who already proven atherosclerotic cardiovascular disease ASCVD such as undergoing percutaneous coronary intervention PCI for coronary artery disease CAD Although Busch et al previously reported that a significant minority of patients are using E-cigarettes post-acute coronary syndrome smokers a paucity of data exists regarding the impact of such transitions on clinical outcomes in current smoker patients with CAD who have undergone PCI In light of these considerations the current study sought to address this gap in knowledge by evaluating the prognostic implications of smoking habit changes including E-cigarette use among CAD patients with current smoking status following PCI
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None